NCT01053403View on ClinicalTrials.gov

Study of the Effects of MDMA/Ecstasy on Water Regulation, Sleep, and Cognition.

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

February 28, 2011

Conditions
MDMA Discontinuation Syndrome
Interventions
DRUG

3,4-methylenedioxymethamphetamine or Placebo

1.5mg/kg MDMA or matched Placebo administered during 2 inpatients stays. There are 2 dosing sessions and all subjects will receive MDMA at least one time.

Trial Locations (1)

94110

CPMC Addiction & Pharmacology Research Laboratory (APRL), San Francisco

Sponsors
All Listed Sponsors
lead

California Pacific Medical Center Research Institute

OTHER